With more than 30 million HIV-infected individuals, there can be few other more pressing biomedical priorities than to produce an effective vaccine for HIV. Given the important role that cytotdxicT lymphocytes (CTLs) and helper Tlymphocytes (HTLs) play in controlling viral replication, it is critical that this vaccine stimulates these cellular responses. Current methods of detecting vaccine-induced immune responses include Intracellular Cytokine Staining (ICS), Enzyme-Linked Spot-Forming Assays (ELISPOT), and tetramer-staining. ICS and ELISPOT can be carried out using peptides of 9-15 amino acids in length. However, depending on where the true epitope lies in the synthetic peptide, these peptide sets may not accurately detect the magnitude of the immune response. Therefore, the identification of minimal optimal epitopes is the only method to accurately assess cellular immune responses. Furthermore, the synthesis of tetramers is absolutely dependent on knowledge of the minimal optimal epitope. We, therefore, propose to continue our definition of minimal optimal epitopes for common Indian rhesus macaque class I and II molecules. Tn Sperifir Aim T- We will identify peptides that bind to seven new MHC class I molecules that restrict SIV-specific epitopes. The highest frequency alleles which have not been characterized yet includeMamu-A*0402, -A*08, -A* 1304, -A* 1403, -B* 12, -B*3003, and-B*5702. In SnecifirAimTT: Wewill identify peptides thatbind toseven new MHC class II molecules that restrict SIV-specific epitopes. The highest frequency alleles which have not been characterized yet include Mamu-DPB 1 *06, -DPB1*10, -DQB1*1801, - DRB1*0306, -DRB1 *0309, -DRB1*1003, and -DRB1*1002. These minimal optimal epitopes will allow us to accurately measure immune responses in vaccinated and infected macaques using ICS and ELISPOT. Furthermore, we will make tetramers important for monitoring immune responses, sorting T cell populations, and detecting antigen-specific T cells .in situ. We will also establish MHC peptide prediction tools which will be made availableto the entire scientific community. These types of reagents have been and will be critical to our understandingof AIDS pathogenesis and AIDS vaccine development. The specifictetramer reagents, the binding assays and the MHC prediction tools will greatly expand our capacity to study immune responses.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Resource-Related Research Projects (R24)
Project #
5R24RR015371-10
Application #
7660378
Study Section
Special Emphasis Panel (ZRR1-CM-1 (01))
Program Officer
Harding, John D
Project Start
2000-07-01
Project End
2010-06-30
Budget Start
2009-07-01
Budget End
2010-06-30
Support Year
10
Fiscal Year
2009
Total Cost
$707,662
Indirect Cost
Name
University of Wisconsin Madison
Department
Veterinary Sciences
Type
Other Domestic Higher Education
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Reynolds, Matthew R; Weiler, Andrea M; Piaskowski, Shari M et al. (2012) A trivalent recombinant Ad5 gag/pol/nef vaccine fails to protect rhesus macaques from infection or control virus replication after a limiting-dose heterologous SIV challenge. Vaccine 30:4465-75
Sette, Alessandro; Sidney, John; Southwood, Scott et al. (2012) A shared MHC supertype motif emerges by convergent evolution in macaques and mice, but is totally absent in human MHC molecules. Immunogenetics 64:421-34
Mudd, Philip A; Martins, Mauricio A; Ericsen, Adam J et al. (2012) Vaccine-induced CD8+ T cells control AIDS virus replication. Nature 491:129-33
Vojnov, Lara; Martins, Mauricio A; Bean, Alexander T et al. (2012) The majority of freshly sorted simian immunodeficiency virus (SIV)-specific CD8(+) T cells cannot suppress viral replication in SIV-infected macrophages. J Virol 86:4682-7
Mudd, Philip A; Ericsen, Adam J; Burwitz, Benjamin J et al. (2012) Escape from CD8(+) T cell responses in Mamu-B*00801(+) macaques differentiates progressors from elite controllers. J Immunol 188:3364-70
Mudd, Philip A; Ericsen, Adam J; Price, Andrew A et al. (2011) Reduction of CD4+ T cells in vivo does not affect virus load in macaque elite controllers. J Virol 85:7454-9
Reynolds, Matthew R; Sacha, Jonah B; Weiler, Andrea M et al. (2011) The TRIM5{alpha} genotype of rhesus macaques affects acquisition of simian immunodeficiency virus SIVsmE660 infection after repeated limiting-dose intrarectal challenge. J Virol 85:9637-40
Mudd, Philip A; Watkins, David I (2011) Understanding animal models of elite control: windows on effective immune responses against immunodeficiency viruses. Curr Opin HIV AIDS 6:197-201
Mudd, Philip A; Ericsen, Adam J; Walsh, Andrew D et al. (2011) CD8+ T cell escape mutations in simian immunodeficiency virus SIVmac239 cause fitness defects in vivo, and many revert after transmission. J Virol 85:12804-10
Vojnov, Lara; Bean, Alexander T; Peterson, Eric J et al. (2011) DNA/Ad5 vaccination with SIV epitopes induced epitope-specific CD4? T cells, but few subdominant epitope-specific CD8? T cells. Vaccine 29:7483-90

Showing the most recent 10 out of 50 publications